Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · IEX Real-Time Price · USD

6.11

-0.10 (-1.61%)

At close: Apr 18, 2024, 4:00 PM

6.15

+0.04 (0.65%)

After-hours: Apr 18, 2024, 6:11 PM EDT

Relay Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-341.97	-290.51	-363.87	-230.2	-75.31	-48.79
Depreciation & Amortization	5.27	4.13	3.93	3.55	2.85	2.15
Share-Based Compensation	86.03	56.14	48.45	31.96	4.46	2.89
Other Operating Activities	-49.64	0.75	237.09	-85.59	1.87	-0.39
Operating Cash Flow	-300.32	-229.49	-74.41	-102.49	-66.13	-44.14
Capital Expenditures	-4.13	-9.06	-3.47	-1.93	-7.98	-1.68
Acquisitions	0	0	-25.3	0	0	0
Change in Investments	261.76	-179.68	-450.74	83.6	-311.04	0
Investing Cash Flow	257.63	-188.75	-479.51	81.67	-319.02	-1.68
Share Issuance / Repurchase	34.75	289.91	388.09	426.51	0.61	0.72
Other Financing Activities	-	-	-	-	4.99	394.26
Financing Cash Flow	34.75	289.91	388.09	426.51	5.61	394.97
Net Cash Flow	-7.93	-128.33	-165.83	405.69	-379.55	349.16
Free Cash Flow	-304.44	-238.55	-77.88	-104.42	-74.12	-45.82
Free Cash Flow Margin	-1191.74%	-17273.86%	-2571.05%	-126.33%	-	-
Free Cash Flow Per Share	-2.48	-2.13	-0.82	-2.45	-21.48	-18.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).